Lucie Marešová

505 total citations
18 papers, 384 citations indexed

About

Lucie Marešová is a scholar working on Epidemiology, Genetics and Virology. According to data from OpenAlex, Lucie Marešová has authored 18 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Genetics and 5 papers in Virology. Recurrent topics in Lucie Marešová's work include Herpesvirus Infections and Treatments (10 papers), Virus-based gene therapy research (9 papers) and Poxvirus research and outbreaks (5 papers). Lucie Marešová is often cited by papers focused on Herpesvirus Infections and Treatments (10 papers), Virus-based gene therapy research (9 papers) and Poxvirus research and outbreaks (5 papers). Lucie Marešová collaborates with scholars based in Czechia, United States and Israel. Lucie Marešová's co-authors include Charles Grose, Tracy Jo Pasieka, Michael A. Mares, Martin Horn, Jiřı́ Vondrášek, Šárka Němečková, Conor R. Caffrey, Viera Ludvı́ková, Erick Gerday and Wallen Jackson and has published in prestigious journals such as Biochemistry, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Lucie Marešová

18 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucie Marešová Czechia 12 221 116 85 67 51 18 384
Viv Connor United Kingdom 13 289 1.3× 42 0.4× 127 1.5× 92 1.4× 61 1.2× 16 420
Kathrin Michael Germany 8 288 1.3× 69 0.6× 84 1.0× 59 0.9× 39 0.8× 8 372
Brian P. Hannah United States 6 351 1.6× 43 0.4× 93 1.1× 53 0.8× 61 1.2× 7 414
Aaron W. Kolb United States 13 359 1.6× 42 0.4× 78 0.9× 75 1.1× 98 1.9× 23 465
Arnault Graindorge France 14 199 0.9× 306 2.6× 60 0.7× 212 3.2× 37 0.7× 22 641
David Pasdeloup France 11 427 1.9× 79 0.7× 166 2.0× 137 2.0× 133 2.6× 13 626
Ute Prank Germany 7 306 1.4× 53 0.5× 145 1.7× 207 3.1× 50 1.0× 7 562
Mahadevaiah Umashankar United States 12 430 1.9× 154 1.3× 113 1.3× 136 2.0× 59 1.2× 16 630
Simon Gras Germany 8 103 0.5× 208 1.8× 38 0.4× 85 1.3× 23 0.5× 10 339
J C Schwab United States 6 239 1.1× 358 3.1× 43 0.5× 133 2.0× 39 0.8× 7 492

Countries citing papers authored by Lucie Marešová

Since Specialization
Citations

This map shows the geographic impact of Lucie Marešová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucie Marešová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucie Marešová more than expected).

Fields of papers citing papers by Lucie Marešová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucie Marešová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucie Marešová. The network helps show where Lucie Marešová may publish in the future.

Co-authorship network of co-authors of Lucie Marešová

This figure shows the co-authorship network connecting the top 25 collaborators of Lucie Marešová. A scholar is included among the top collaborators of Lucie Marešová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucie Marešová. Lucie Marešová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Vondrášek, Jiřı́, Lucie Marešová, Martin Hubálek, et al.. (2018). SmSP2: A serine protease secreted by the blood fluke pathogen Schistosoma mansoni with anti-hemostatic properties. PLoS neglected tropical diseases. 12(4). e0006446–e0006446. 27 indexed citations
2.
Proška, Jan, Lucie Marešová, Marek Procházka, Eugenie Nepovimová, & Kamil Kuča. (2018). DETECTION OF ALZHEIMER’S DRUG CANDIDATE BY SURFACE-ENHANCED RAMAN SPECTROSCOPY. 87. 126–126. 1 indexed citations
3.
Brynda, J., Nawsad Alam, Daniel Sojka, et al.. (2018). Novel Structural Mechanism of Allosteric Regulation of Aspartic Peptidases via an Evolutionarily Conserved Exosite. Cell chemical biology. 25(3). 318–329.e4. 18 indexed citations
4.
Horn, Martin, Pavlína Řezáčová, Lucie Marešová, et al.. (2014). Activation Route of the Schistosoma mansoni Cathepsin B1 Drug Target: Structural Map with a Glycosaminoglycan Switch. Structure. 22(12). 1786–1798. 28 indexed citations
5.
Lepšı́k, Martin, et al.. (2012). Enzymatic activity and immunoreactivity of Aca s 4, an alpha-amylase allergen from the storage mite Acarus siro. BMC Biochemistry. 13(1). 3–3. 13 indexed citations
7.
Marešová, Lucie, et al.. (2008). Comparative Analyses of the 9 Glycoprotein Genes Found in Wild‐Type and Vaccine Strains of Varicella‐Zoster Virus. The Journal of Infectious Diseases. 197(s2). S49–S53. 19 indexed citations
8.
Marešová, Lucie, et al.. (2006). Cathepsin D Propeptide:  Mechanism and Regulation of Its Interaction with the Catalytic Core. Biochemistry. 45(51). 15474–15482. 34 indexed citations
9.
Pasieka, Tracy Jo, Lucie Marešová, Kimíyasu Shiraki, & Charles Grose. (2004). Regulation of Varicella-Zoster Virus-Induced Cell-to-Cell Fusion by the Endocytosis-Competent Glycoproteins gH and gE. Journal of Virology. 78(6). 2884–2896. 26 indexed citations
10.
Marešová, Lucie, et al.. (2004). Incorporation of Three Endocytosed Varicella-Zoster Virus Glycoproteins, gE, gH, and gB, into the Virion Envelope. Journal of Virology. 79(2). 997–1007. 36 indexed citations
11.
Pasieka, Tracy Jo, Lucie Marešová, & Charles Grose. (2003). A Functional YNKI Motif in the Short Cytoplasmic Tail of Varicella-Zoster Virus Glycoprotein gH Mediates Clathrin-Dependent and Antibody-Independent Endocytosis. Journal of Virology. 77(7). 4191–4204. 32 indexed citations
12.
Marešová, Lucie, et al.. (2003). Identification of the authentic varicella-zoster virus gB (gene 31) initiating methionine overlapping the 3? end of gene 30. Journal of Medical Virology. 70(S1). S64–S70. 9 indexed citations
13.
Němečková, Šárka, L Kutinová, Pavel Otáhal, et al.. (2002). Immune response to E7 protein of human papillomavirus type 16 anchored on the cell surface. Cancer Immunology Immunotherapy. 51(2). 111–119. 11 indexed citations
14.
Kutinová, L, et al.. (2001). Immune Response to Vaccinia Virus Recombinants Expressing Glycoproteins gE, gB, gH, and gL of Varicella-Zoster Virus. Virology. 280(2). 211–220. 10 indexed citations
15.
Marešová, Lucie, Tracy Jo Pasieka, & Charles Grose. (2001). Varicella-Zoster Virus gB and gE Coexpression, but Not gB or gE Alone, Leads to Abundant Fusion and Syncytium Formation Equivalent to Those from gH and gL Coexpression. Journal of Virology. 75(19). 9483–9492. 57 indexed citations
16.
Marešová, Lucie, et al.. (2000). Characterization of interaction of gH and gL glycoproteins of varicella-zoster virus: their processing and trafficking. Journal of General Virology. 81(6). 1545–1552. 21 indexed citations
18.
Němečková, Šárka, et al.. (1996). Induction of varicella-zoster virus-neutralizing antibodies in mice by co-infection with recombinant vaccinia viruses expressing the gH or gL gene. Journal of General Virology. 77(2). 211–215. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026